Marzia V. Palma
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Demographic and clinical profiles of patients with primary and second primary cancers: identifying biomarkers of sensitivity to radiotherapy-induced cancer.
Journal: International journal of radiation biology
Published: February 23, 2026
Baseline plasma-informed circulating tumor DNA analyses comparing multiplex digital PCR and NGS for longitudinal monitoring in Hodgkin lymphoma.
Journal: Blood cancer journal
Published: December 17, 2025
T-cell immunomodulation occurs with different time kinetics during acalabrutinib and zanubrutinib therapy in chronic lymphocytic leukaemia.
Journal: British journal of haematology
Published: October 01, 2025
A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).
Journal: Cancers
Published: September 20, 2024
Frequent response monitoring in chronic lymphocytic leukemia clinical trials: what is the value?
Journal: Blood neoplasia
Published: November 03, 2023
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 07, 2023
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region.
Journal: European journal of haematology
Published: June 05, 2023
Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia.
Journal: Journal of hematology
Published: May 14, 2023
Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment.
Journal: HemaSphere
Published: July 04, 2022
Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?
Journal: Scandinavian journal of immunology
Published: February 10, 2022
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 25, 2022
Nitrogen dioxide pollution increases vulnerability to COVID-19 through altered immune function.
Journal: Environmental science and pollution research international
Published: October 19, 2021
Last Updated: 09/26/2026